Treatment of renal carcinoma: a phase III randomized trial of oral medroxyprogesterone (Provera), hydroxyurea, and nafoxidine.

Source:http://linkedlifedata.com/resource/pubmed/id/6454485

Download in:

View as

General Info

PMID
6454485